Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.9600 (5.57%) ($7.7000 - $8.5000) on Fri. Jul. 31, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.51% (three month average) | RSI | 78 | Latest Price | $7.9600(5.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.6% a day on average for past five trading days. | Weekly Trend | CAPR advances 37.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BNDX(55%) BND(28%) BWX(21%) CEMB(20%) EDOC(20%) | Factors Impacting CAPR price | CAPR will decline at least -4.255% in a week (0% probabilities). XOP(-22%) XLI(-22%) XLB(-21%) VYM(-21%) PAVE(-21%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.255% (StdDev 8.51%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
5 Day Moving Average | $8.83(-9.85%) | 10 Day Moving Average | $7.74(2.84%) | 20 Day Moving Average | $6.21(28.18%) | To recent high | -18.9% | To recent low | 58.9% | Market Cap | $157m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |